.webp)
The global DNA data storage market size is calculated at USD 150.63 million in 2025 and is predicted to increase from USD 283.21 million in 2026 to approximately USD 44,213.05 million by 2034, expanding at a CAGR of 88.01% from 2025 to 2034. The DNA data storage market is an emerging sector poised for significant growth as demand for efficient, high-density data storage solutions increases. With advancements in synthetic biology and biotechnology, DNA stands out as a viable medium for storing vast amounts of data.
The global CRISPR-based diagnostics market size is anticipated at USD 3.79 billion in 2025 and is predicted to increase from USD 4.42 billion in 2026 to approximately USD 15.14 billion by 2034, expanding at a CAGR of 16.63% from 2025 to 2034. The market growth is attributed to growing disease burden, increasing demand for accurate diagnostics and point-of-care testing, as well as growing innovations and the application of CRISPR-based diagnostics.
The U.S. artificial intelligence in biotechnology market size is calculated at USD 2.10 billion in 2025 and is predicted to increase from USD 2.51 billion in 2026 to approximately USD 10.46 billion by 2034, expanding at a CAGR of 19.51% from 2025 to 2034. The U.S. artificial intelligence in biotechnology market is driven by AI adoption in drug discovery, precision medicine, and genomics, supported by strong R&D and advanced infrastructure.
The global fluorescent in situ hybridization (FISH) probe market size is calculated at USD 1.14 billion in 2025 and is predicted to increase from USD 1.23 billion in 2026 to approximately USD 2.27 billion by 2034, expanding at a CAGR of 7.93% from 2025 to 2034. The rising prevalence of genetic disorders and cancer, coupled with the growing adoption of precision diagnostics, is propelling strong growth in the global fluorescent in situ hybridization (FISH) probe market.
The global neurovascular thrombectomy devices market size accounted for USD 825.92 million in 2025 and is predicted to increase from USD 882.16 million in 2026 to approximately USD 1,494.32 million by 2034, expanding at a CAGR of 6.81% from 2025 to 2034. This market is growing due to the increasing prevalence of neurovascular disorders and the rising adoption of minimally invasive treatments.
The global software as a service for behavioural health market is expanding rapidly with increasing adoption of cloud platforms for therapy management, telehealth, and analytics. This market is growing as demand for accessible, scalable, and integrated digital solutions for mental health and wellness management increases.
The global minimally invasive medical robots market size accounted for USD 58.20 billion in 2025 and is predicted to increase from USD 66.10 billion in 2026 to approximately USD 183.07 billion by 2034, expanding at a CAGR of 13.58% from 2025 to 2034. The market is driven by rising demand for precise, less invasive surgeries and advancements in robotics technology.
The global pharmaceutical lipid-based excipients market size is calculated at USD 2.02 billion in 2025 and is predicted to increase from USD 2.12 billion in 2026 to approximately USD 3.17 billion by 2034, expanding at a CAGR of 5.13% from 2025 to 2034. The rising demand for liquid formulations and advances in drug delivery technologies are fueling the growth of the global pharmaceutical lipid-based excipients market.
The global spinal access systems market size is calculated at USD 6.30 billion in 2025 and is predicted to increase from USD 6.71 billion in 2026 to approximately USD 11.05 billion by 2034, expanding at a CAGR of 6.44% from 2025 to 2034. The market is experiencing robust growth, driven by the rising prevalence of spinal disorders, an aging global population, and significant investments in advancing healthcare infrastructure.
The U.S. pharmaceutical market size accounted for USD 520.38 billion in 2025 and is predicted to increase from USD 552.72 billion in 2026 to approximately USD 907.86 billion by 2034, expanding at a CAGR of 6.34% from 2025 to 2034. The market is witnessing substantial growth due to the rising demand for personalized and regenerative therapies for chronic diseases. This expansion is fueled by technological advancements, notably the integration of AI and machine learning, which accelerate R&D and drug discovery in the upcoming years.
The global celiac disease treatment market size is calculated at USD 784.59 million in 2025 and is predicted to increase from USD 879.06 million in 2026 to approximately USD 2,182.74 million by 2034, expanding at a CAGR of 12.04% from 2025 to 2034. The market is experiencing significant growth due to increased diagnosis, disease awareness, and ongoing research into new therapies.
The global liver cancer drug market size accounted for USD 4.39 billion in 2025 and is predicted to increase from USD 5.19 billion in 2026 to approximately USD 19.65 billion by 2034, expanding at a CAGR of 18.11% from 2025 to 2034. The global liver cancer drug market is experiencing significant growth, driven by the increased liver cancer prevalence and advancements in treatment potions like antiviral and immunosuppressive therapies.
The global microinsurance market size accounted for USD 89.06 billion in 2025 and is predicted to increase from USD 95.15 billion in 2026 to approximately USD 161.54 billion by 2034, expanding at a CAGR of 6.84% from 2025 to 2034. The market growth is attributed to increasing smartphone penetration, mobile money adoption, which enables efficient, low-cost, and accessible insurance solutions for underserved populations.
The global organ-on-a-chip market size accounted for USD 227.40 million in 2025 and is predicted to increase from USD 307.61 million in 2026 to approximately USD 3,448.33 million by 2034, expanding at a CAGR of 35.27% from 2025 to 2034. More accurate preclinical testing can decrease the rate of drug candidate failure in later clinical trials, even saving time and resources. These systems provide precise control over the experimental environment, permitting the study of dynamic processes such as tissue interfaces, stress, and cell-cell interactions that are challenging to replicate in other settings.
The global real world evidence solutions market size is calculated at USD 3.32 billion in 2025 and is predicted to increase from USD 3.60 billion in 2026 to approximately USD 6.92 billion by 2034, expanding at a CAGR of 8.51% from 2025 to 2034. The market is driven by the increasing adoption of data-driven decision-making in drug development, regulatory approvals, and healthcare outcomes optimization.
The global personalized testing and supplements market size is calculated at USD 5.39 billion in 2025 and is predicted to increase from USD 5.61 billion in 2026 to approximately USD 7.74 billion by 2034, expanding at a CAGR of 16.22% from 2025 to 2034. The market growth is attributed to increasing consumer demand for personalized health solutions and wellness analytics services.
The global alzheimer therapeutics market size accounted for USD 6.49 billion in 2025 and is predicted to increase from USD 7.79 billion in 2026 to approximately USD 33.62 billion by 2034, expanding at a CAGR of 20.06% from 2025 to 2034. The increased prevalence of Alzheimer’s disease and advancements in disease-modifying therapies are driving the global Alzheimer therapeutics market.
The global antimycotics market size accounted for USD 17.50 billion in 2025 and is predicted to increase from USD 18.21 billion in 2026 to approximately USD 25.04 billion by 2034, expanding at a CAGR of 4.06% from 2025 to 2034. This market is growing due to the rising prevalence of fungal infections worldwide and increasing demand for effective antifungal therapies.
The global nuclear medicine software market size is calculated at USD 978.76 million in 2025 and is predicted to increase from USD 1069.01 million in 2026 to approximately USD 2164.70 million by 2034, expanding at a CAGR of 9.22% from 2025 to 2034. The rising prevalence of chronic and life-threatening diseases such as cardiovascular disorders (CVDs) and cancer is driving the demand for advanced diagnostic tools. This, in turn, is propelling market growth through the integration of AI and machine learning technologies with nuclear medicine software.
The global metformin market size is calculated at USD 4.50 billion in 2025 and is predicted to increase from USD 4.79 billion in 2026 to approximately USD 7.99 billion by 2034, expanding at a CAGR of 6.59% from 2025 to 2034. The market is driven by increasing prevalence of type 2 diabetes, growing aging population, rising awareness about diabetes management, and advancements in pharmaceutical inventions.
The global molecular cytogenetics market size is calculated at USD 2.86 billion in 2025 and is predicted to increase from USD 3.20 billion in 2026 to approximately USD 7.82 billion by 2034, expanding at a CAGR of 11.81% from 2025 to 2034. The growth of the molecular cytogenetics market is driven by the growing adoption of advanced genomic technologies for the precise detection of genetic abnormalities in cancer and congenital disorders.
The global circulating biomarkers market size is calculated at USD 5.17 billion in 2025 and is predicted to increase from USD 5.78 billion in 2026 to approximately USD 14.22 billion by 2034, expanding at a CAGR of 11.90% from 2025 to 2034. The global circulating biomarkers market is experiencing robust growth, driven by the increasing prevalence of chronic disease diagnostics, growing demand for personalized medicine, a surge in regulatory approvals, increasing need for early & non-invasive detection methods, and rising investments in healthcare infrastructure. This report covers market trends, production volumes, technological developments, and competitive dynamics across North America, Europe, and APAC between 2025 and 2030."
The global incretin mimetics market size is calculated at USD 24.36 billion in 2025 and is predicted to increase from USD 25.59 billion in 2026 to approximately USD 38.01 billion by 2034, expanding at a CAGR of 5.07% from 2025 to 2034. The market for incretin mimetics stands as a transformative frontier in diabetic care, blending pharmacological precision with physiological harmony. As metabolic disorders continue to escalate worldwide, these agents are designed to mimic natural incretin hormones.
The global gel documentation systems market size is calculated at USD 373.87 million in 2025 and is predicted to increase from USD 396.98 million in 2026 to approximately USD 641.37 million by 2034, expanding at a CAGR of 6.18% from 2025 to 2034. The market growth is attributed to the expanding adoption of advanced imaging technologies in molecular biology and clinical diagnostics.
The global next-generation sequencing library preparation market size is calculated at USD 2.07 billion in 2025 and is predicted to increase from USD 2.34 billion in 2026 to approximately USD 6.44 billion by 2034, expanding at a CAGR of 13.47% from 2025 to 2034. This market is growing due to increasing demand for precise genomic analysis and advancements in sequencing technologies.
The global Type 2 diabetes management market uncovers key drivers such as increasing healthcare expenditure, aging populations and regulatory support for diabetes education and self-management programs. The market is witnessing remarkable growth as global health systems increasingly prioritize chronic disease prevention and personalized care.
The global dermo cosmetics market size is calculated at USD 48.76 billion in 2025 and is predicted to increase from USD 53.84 billion in 2026 to approximately USD 118.99 billion by 2034, expanding at a CAGR of 10.42% from 2025 to 2034. increasing consumer awareness of skin health and a rise in chronic skin conditions like acne and eczema.
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs. The growth of the market is driven by rising diabetes prevalence and growing demand for simplified, effective combination therapies.
The global SGLT-2 inhibitors market size is calculated at USD 18.18 billion in 2025 and is predicted to increase from USD 19.31 billion in 2026 to approximately USD 31.34 billion by 2034, expanding at a CAGR of 6.24% from 2025 to 2034. The SGLT-2 inhibitors market is driven by rising diabetes prevalence, expanding therapeutic applications, and increasing adoption of combination therapies globally.
The global minimal residual disease (MRD) testing market size is calculated at USD 1.70 billion in 2025 and is predicted to increase from USD 1.91 billion in 2026 to approximately USD 4.72 billion by 2034, expanding at a CAGR of 12.00% from 2025 to 2034. The market is experiencing substantial growth due to the rising prevalence of cancer, the shift toward personalized medicine, and the increased use of MRD testing in clinical trials. Market growth is significantly driven by demand for highly sensitive technologies like next-generation sequencing (NGS) and digital PCR (dPCR), which accurately detect minimal residual cancer cells to guide treatment decisions and predict patient outcomes.
The global circulating tumor DNA (ctDNA) market size is calculated at USD 7.96 billion in 2025 and is predicted to increase from USD 9.14 billion in 2026 to approximately USD 27.67 billion by 2034, expanding at a CAGR of 14.85% from 2025 to 2034. Growth in precision oncology, demand for targeted therapies, and advancements in next-generation sequencing (NGS) technology are driving the growth of the circulating tumor DNA (ctDNA) market.
The global feline vaccines market size is calculated at USD 1.77 billion in 2025 and is predicted to increase from USD 1.89 billion in 2026 to approximately USD 3.28 billion by 2034, expanding at a CAGR of 7.12% from 2025 to 2034. The global feline vaccines market is witnessing robust growth, driven by rising pet humanization trends, rising pet ownership, increasing awareness of preventative healthcare for cats, and significant investments in veterinary healthcare infrastructure. This report covers market trends, production volumes, technological developments, and competitive dynamics across North America, Europe, and APAC between 2025 and 2030.
The global microbiology and bacterial culture media market size accounted for USD 6.03 billion in 2025 and is predicted to increase from USD 6.58 billion in 2026 to approximately USD 13.22 billion by 2034, expanding at a CAGR of 9.11% from 2025 to 2034. The microbiology and bacterial culture media market is driven by rising infectious diseases, rigorous food and pharmaceutical safety regulations, technological advancements, and increased R&D in biotechnology and vaccine development.
The global bioprocess validation market size is calculated at USD 537.30 million in 2025 and is predicted to increase from USD 586.36 million in 2026 to approximately USD 1,179.55 million by 2034, expanding at a CAGR of 9.13% from 2025 to 2034. The market is experiencing substantial growth due to the increasing adoption of advanced biomanufacturing technologies, including cell and gene therapies. This demand is further fueled by the need for platforms capable of aggregating and analyzing multi-source data in real time to support Continued Process Verification (CPV) and meet regulatory compliance requirements. The integration of smart sensors (IoT) and AI is accelerating workflow automation and process optimization, ensuring consistent product quality and safety.
The global human fibrinogen concentrates market size is calculated at USD 1.33 billion in 2025 and is predicted to increase from USD 1.43 billion in 2026 to approximately USD 2.50 billion by 2034, expanding at a CAGR of 7.26% from 2025 to 2034. The increased numbers of surgical procedures and prevalence of bleeding disorders are driving the growth of the human fibrinogen concentrates market.
The global minimally invasive medical imaging market driven by rising chronic disease prevalence, technological innovations in ultrasound/CT/MRI and growing patient demand for less traumatic diagnostics. The minimally invasive medical imaging market growth is driven by the increasing preference for minimally invasive surgeries, technological advancements in imaging systems, and a rising demand for early and accurate diagnostics.
The global flash chromatography market size was calculated at USD 264.94 million in 2025 and is predicted to increase from USD 278.38 million in 2026 to approximately USD 413.49 million by 2034, expanding at a CAGR of 5.07% from 2025 to 2034. The market stands as a cornerstone of modern separation science, enabling swift and efficient purification of chemical mixtures in laboratories worldwide.
The global induced pluripotent stem cell (iPSC) therapy market growth is fueled by stem-cell R&D funding, clinical translation of iPSC therapeutics and expanding cell-therapy pipelines. The market is witnessing substantial growth due to increasing demand for personalized medicine and regenerative therapies for chronic diseases. Its expansion is further fueled by technological advances that enhance iPSC production efficiency and scalability. Additionally, the integration of AI and machine learning is accelerating research and development, propelling market growth.
The global restorative dentistry market size is calculated at USD 24.60 billion in 2025 and is predicted to increase from USD 26.55 billion in 2026 to approximately USD 48.93 billion by 2034, expanding at a CAGR of 7.94% from 2025 to 2034. Restorative dentistry focuses on repairing and restoring damaged teeth to improve oral health and functionality. It encompasses various treatments aimed at restoring the natural appearance and strength of teeth, contributing to overall dental wellness.
The global EEG-based biometrics market size was calculated at USD 2.74 billion in 2025 and is predicted to increase from USD 2.98 billion in 2026 to approximately USD 5.94 billion by 2034, expanding at a CAGR of 9.00% from 2025 to 2034. The increased demand for secure and efficient biometric solutions is driving the global market. Growing emphasis on health monitoring is further contributing to this growth.
The global in-silico drug discovery market size was calculated at USD 4.17 billion in 2025 and is predicted to increase from USD 4.63 billion in 2026 to approximately USD 10.73 billion by 2034, expanding at a CAGR of 11.09% from 2025 to 2034.
The global active pharmaceutical ingredients CDMO market size was calculated at USD 116.77 billion in 2025 and is predicted to increase from USD 125.99 billion in 2026 to approximately USD 231.48 billion by 2034, expanding at a CAGR of 7.90% from 2025 to 2034. The market is experiencing significant growth, as pharmaceutical companies are outsourcing API manufacturing to reduce costs and scale production. Additionally, rising demand for complex APIs, such as biologics and highly potent compounds, along with the need to diversify supply chains, mitigate risks, enhance operational efficiency, and accelerate time-to-market, are fueling further expansion.
The global oral solid dose oncology CDMO market is driven by growing demand for efficient, scalable cancer drug manufacturing and formulation support. The market is experiencing significant growth, driven by the rising demand for effective cancer treatments in solid dosage forms. With an increasing number of oncology therapies being developed and launched, contract development and manufacturing organizations (CDMOs) play a crucial role in supporting pharmaceutical companies. This dynamic market is anticipated to expand from its current valuation, reaching impressive figures over the next decade.
The global mental health digital therapeutics (DTx) market is witnessing rapid growth as digital platforms deliver clinically validated treatments for mental health conditions. This market is growing due to increasing awareness about mental well-being and the rising adoption of technology-driven, accessible treatment solutions.
The global regenerative aesthetics market size was calculated at USD 3.76 billion in 2025 and is predicted to increase from USD 4.04 billion in 2026 to approximately USD 7.15 billion by 2034, expanding at a CAGR of 7.40% from 2025 to 2034. The regenerative aesthetics market is a rapidly growing sector focused on advanced cosmetic and medical treatments aimed at tissue repair and rejuvenation. It is shaping the future of aesthetic procedures by emphasizing innovative, minimally invasive solutions that promote natural beauty.
The global quantum sensing medical imaging market size accounted for USD 344.23 million in 2025 and is predicted to increase from USD 370.11 million in 2026 to approximately USD 661.07 million by 2034, expanding at a CAGR of 7.52% from 2025 to 2034. This market is growing due to the unprecedented precision and sensitivity of quantum sensors.
The global psychedelic API market size was calculated at USD 4.75 billion in 2025 and is predicted to increase from USD 5.47 billion in 2026 to approximately USD 16.93 billion by 2034, expanding at a CAGR of 15.18% from 2025 to 2034. The global psychedelic API market experiencing significant growth, driven by increasing clinical research, expanding therapeutic applications, and rising interest in mental health treatments using psychedelics.
The global psychedelic therapeutics market size was estimated at USD 2.94 billion in 2025 and is predicted to increase from USD 3.41 billion in 2026 to approximately USD 11.03 billion by 2034, expanding at a CAGR of 15.82% from 2025 to 2034. The psychedelic therapeutics market is rapidly emerging as a transformative frontier in mental health treatment, driven by growing clinical validation and regulatory momentum for psychedelic-assisted therapies.
The global regenerative medicine in dermatology market offers insights into innovations in stem cell, exosome, and tissue engineering approaches for skin rejuvenation. The market is witnessing substantial growth due to rising skin condition prevalence, from chronic wounds to aesthetic concerns, and demand for advanced treatments. Innovations in cell therapies and bioengineered skin offer improved healing and appearance, while personalized products expand applications beyond aesthetics.
The global precision dermatology market is transforming dermatological care by enabling customized treatment plans for conditions like psoriasis, acne, and eczema. Technological advancements in laser and light-based skin treatments and digital imaging are fueling the growth of the global precision dermatology market.
